India, Pfizer seek to bridge dispute over vaccine indemnity Pfizer
(PFE.N) and the Indian government are seeking to resolve tensions over a demand by the U.S. drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world’s biggest markets, two sources told Reuters
قراءة المزيد